一名乡镇医生给村里王大爷的孙子开了一张处方：患者：男，年龄：4 岁，诊断：上呼吸道感染注射用头孢曲松钠 1 g+注射用地塞米松磷酸钠 2 mg+0.9...，静脉滴注注射用头孢曲松钠 1 g+5% 葡糖糖注射液 100 ml，静脉滴注共计：17.2 元处方问题很大，引发争议看到这张处方，外行人觉得大赞，17.2 元就治好

【编者按】近期，哥伦比亚大学医学中心的Généreux博士等在JACC上发表了一篇关于经导管主动脉瓣置换术后主要晚期出血并发症及其与死亡率之间关系的文章，来自...预后的影响至关重要。为此，来自美国哥伦比亚大学医学中心的Généreux博士等进行了一项研究，研究发现经导管主动脉瓣置换术后主要晚期出血并发症常见，且增加死亡率

为促进中外肿瘤专家学术交流，和睦家肺癌诊疗中心与和睦家启望肿瘤中心将在 11 月 21 日下午 7：00 面向医疗同道共同举办海外名医讲堂，特邀哈佛大学医院附属麻省总医院 Dr. Christopher G. Azzoli 医生连线分享《非小细胞性肺癌（NSCLC）治疗 2017 年新进展》，欢迎多学科专家共同参与

Background. Children are highly vulnerable to infection with novel influenza viruses. It is essential to develop candidate pandemic influenza vaccines which are safe and effective in the pediatric population.Methods. Infants and children aged 6-35 months and 3-8 years were randomized to receive two immunizations with a 7.5 µg or 3.75 µg hemagglutinin (HA) dose of a non-adjuvanted whole-virus A/Vietnam strain H5N1 vaccine; adolescents aged 9-17 years received a 7.5 µg dose only. A subset of participants received a booster immunization with an A/Indonesia strain H5N1 vaccine approximately one year later. HA and neuraminidase antibody responses were assessed.Results. Vaccination was safe and well-tolerated; adverse reactions were transient and predominantly mild. Two immunizations with the 7.5 µg dose of A/Vietnam vaccine induced virus neutralization (MN) titers ≥1:20 against the A/Vietnam strain in 68.8% to 85.4% of participants in the different age groups. After the booster, 93.1% to 100% of participants achieved MN titers ≥1:20 against the A/Vietnam and A/Indonesia strains. NA-inhibiting antibodies were induced in ≥90% of participants after two immunizations with the 7.5 µg A/Vietnam vaccine and in 100% of participants after the booster.Conclusions. A whole-virus H5N1 vaccine is suitable for pre-pandemic or pandemic immunization in a pediatric population.

对肺结核的诊断-50对呼吸道的管理-104对肺不张的治疗-85对气道异物的诊断-63支气管镜用处置具-83各种类型的硬质异物钳-82对耐药性肺结核的治疗-78

原因-47紧急通气技术-52留置气管内导管期间并发症-82插管前麻醉-28

保钾利尿剂-21补充电解质-67补充电解质-66补充电解质-68布美他尼-16长期使用袢利尿剂-50布美他尼-17大量心包积液-37氮质血症-74氮质血症-75氮质血症-76电解质紊乱-64电解质紊乱-65对策-57肥厚型心肌病 -38定期复查-82肺水肿-26服用利尿剂应遵守的

病因病理-82X线造影表现-93病因病理-41病因病理-100病因病理 -4病因病理 -20病因病理 -30病因病理 -74第三蠕动波-98短食管性食道裂孔疝-25病因病理-62对照-12反流性食道炎（合并短食管型食道裂孔疝）-11反流性食道炎（龛影

GERD的综合治疗-82GERD – 3 种表现形式-81GERD 抗反流屏障-78HP的治疗-70GERD治疗方法-85GERD发病机理的新认识-79HP与胃肠道四种疾病密切相关-68HP根除方案中的抗生素选择-71按需治疗的原则-86病因-55不同pH对血小板聚集率的影响-59长效生长抑素

治疗原发基础疾病-58非酒精性脂肪性肝病-52脂肪性肝病的治疗-82非酒精性脂肪性肝病

急性脑内血肿-82急性脑损伤的临床分级-90挤压性损伤-51继发性

HPS的四大血流动力学特征-74PM–DM并发恶性肿瘤-50八、显微镜下多血管炎-67白血病-82闭塞性细支气管炎伴机化性肺炎（BOOP）-19二、系统性红斑狼疮-21

肺结核-1肺结核并发症-82肺结核并发症-81肺结核并发症-83肺结核并发症-85肺结核并发症-84肺结核并发症-87肺结核并发症

物相互作用-74降糖药物相互作用-75疗程-82流行病学-78

ACEI-90α阻滞剂-95β受体阻滞剂-82ATⅡ受体阻滞剂-91α阻滞剂-94β受体阻滞剂-83β

病原学-82病原学-81成人麻疹-38出疹期-30出疹期

-5病毒性肝炎-1病毒性肝炎-2病理解剖-67病理生理-82

外伤性化脓性骨髓炎-81外伤性化脓性骨髓炎x线-82x线表现-84x线片-85x线表现-90x线表现-91x线片-92结核性关节炎

DNA。而约82%的这些肿瘤中具有MRE11基因突变。澳大医学院血液/肿瘤学研究员该研究的主要作者Eduardo Vilar-Sanchez说